Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early clot resolution in neonates: time to rethink duration of anticoagulation in neonatal catheter-related venous thromboembolism?

Research and practice in thrombosis and haemostasis·2026
Same author

Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial.

JAMA·2025
Same author

Thromboprophylaxis in Children: Navigating Uncharted Waters.

Hamostaseologie·2025
Same author

Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit.

Thrombosis and haemostasis·2024
Same author

Lightening the load for paediatric ITP: The importance of health-related quality of life.

British journal of haematology·2024
Same author

The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia.

Blood advances·2024

Related Experiment Video

Updated: Feb 2, 2026

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.6K

Neonatal ECMO.

Cornelia Heleen Van Ommen1, Cindy E Neunert2, Meera B Chitlur3

  • 1Department of Pediatric Hematology, Sophia Children's Hospital Erasmus MC, Rotterdam, Netherlands.

Frontiers in Medicine
|November 10, 2018
PubMed
Summary
This summary is machine-generated.

Managing anticoagulation for neonates undergoing extracorporeal membrane oxygenation (ECMO) is complex due to their immature hemostatic systems, increasing risks of bleeding and clotting. Expertise in developmental hemostasis is crucial for safe anticoagulation management in these infants.

Keywords:
ECMOanticoagulationcomplicationsmonitoringneonate

More Related Videos

Anatomically Realistic Neonatal Heart Model for Use in Neonatal Patient Simulators
10:05

Anatomically Realistic Neonatal Heart Model for Use in Neonatal Patient Simulators

Published on: February 5, 2019

6.4K
Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

61.4K

Related Experiment Videos

Last Updated: Feb 2, 2026

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.6K
Anatomically Realistic Neonatal Heart Model for Use in Neonatal Patient Simulators
10:05

Anatomically Realistic Neonatal Heart Model for Use in Neonatal Patient Simulators

Published on: February 5, 2019

6.4K
Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

61.4K

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Hematology

Background:

  • Extracorporeal membrane oxygenation (ECMO) is increasingly used for neonates with cardiac and respiratory failure.
  • ECMO requires extensive anticoagulation, posing significant risks in neonates.
  • Neonates have immature hemostatic systems, complicating anticoagulation management.

Purpose of the Study:

  • To provide an overview of the developing hemostatic system in neonates.
  • To highlight the challenges in managing anticoagulation for neonates on ECMO.
  • To emphasize the need for specialized expertise in this area.

Main Methods:

  • Review of the literature on neonatal hemostasis.
  • Discussion of anticoagulation strategies in neonatal ECMO.
  • Analysis of laboratory techniques for monitoring anticoagulation.

Main Results:

  • Neonatal hemostasis differs significantly from adult hemostasis.
  • Current laboratory methods have limitations in accurately assessing neonatal coagulation.
  • Anticoagulation titration is challenging, leading to high risks of hemorrhage and thrombosis.

Conclusions:

  • Managing anticoagulation in neonates on ECMO is exceptionally challenging.
  • Physicians require deep knowledge of neonatal hemostasis and laboratory limitations.
  • Further research is needed to improve anticoagulation monitoring and management in this population.